FDA

Zebra Medical Receives FDA Clearance for its Brain Hemorrhage Alert Technology

17.06.19 | Adi Pick

Itamar Medical Receives FDA Approval for Sleep Apnea Monitor

06.06.19 | Tzally Greenberg

Zebra Medical Receives FDA Clearance for Automated Chest X-Ray Analysis Algorithm

13.05.19 | Meir Orbach

FDA Approves Teva’s Generic Nasal Spray for Opioid Overdose

21.04.19 | Lilach Baumer

Heart Care 3D Visualization Startup CathWorks Gets FDA Approval

26.12.18 | CTech

Cervical Cancer Detection Startup Biop Gets FDA Approval

18.12.18 | CTech

Teva, Celltrion Gain FDA Approval for Generic Blood Cancer Bio-Drug

29.11.18 | Lilach Baumer

Teva’s Generic EpiPen Now Available in the U.S. in Limited Numbers

28.11.18 | Lilach Baumer

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18 | Lilach Baumer

Teva Shares Rise Following FDA Approval of Migraine Drug

16.09.18 | Dror Reich

FDA Approves Brainsway’s Magnetic Stimulation Headset for OCD Treatment

19.08.18 | CTech

Teva Wins FDA Approval for First Generic EpiPen

19.08.18 | Lilach Baumer

Medical Analytics Company DiA Imaging Raises $5 Million

08.08.18 | CTech

Mobile Phone Urine Testing Kit Receives FDA Approval

26.07.18 | Tofi Stoler

Kleiner Perkins, Alphabet Back Stroke Detection Startup Viz.ai

18.07.18 | Meir Orbach

Following FDA Clearance, BioSight to Launch Clinical Trial for Treatment of Leukemia

15.07.18 | CTech

Sustained Drug Release Company UroGen Submits New Drug Application to FDA

12.07.18 | Amir Rosenbaum

MediWound’s Pineapple-Based Burn Treatment to Treat Mustard Gas Burns

31.05.18 | Dror Reich

CTech's Tuesday Roundup of Israeli Tech News

24.04.18 | CTech

AI Healthcare Company Viz.ai Receives FDA Clearance for Stroke Detection Technology

23.04.18 | Hagar Ravet

ReWalk Launches Clinical Trials for Robotic Physical Rehab Suit

04.04.18 | Asaf Shalev

Israeli Telehealth Startup Tyto Care Raises $21 Million

28.01.18 | Meir Orbach

Kite Pharma’s Cancer Drug Gets Regulatory Nod

19.10.17 | Lilach Baumer

Teva Submits Potential Moneymaker Migraine Drug for FDA Approval

18.10.17 | Dror Reich and Lilach Baumer

Teva’s Stock Drops After Approval of Copaxone Competitors

08.10.17 | Lilach Baumer

Teva Loses Copaxone Market Exclusivity

04.10.17 | Lilach Baumer

Developer Of Anti-Rabies Drug Jumps on FDA Approval

27.08.17 | Dror Reich